Novocure

Novocure: EF-32: Pivotal, Randomized, open-label study of Tumor Treating Fields (Optune®, 200kHz) concomitant with radiation therapy and temozolomide for the treatment of Newly Diagnosed Glioblastoma
NCT04771844

Download PDF Flyer